Topics

Medulloblastoma | Treatment | Immunotherapy | Viruses

Home > Publications > Topics > Medulloblastoma > Treatment > Immunotherapy > Viruses

Yu B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J, Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S, Margol A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS, Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K, Kasahara N, Diaz AA, Mueller S.
Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor: results from PNOC005.
Clin Cancer Res. 2025 Jun 20. doi: 10.1158/1078-0432.CCR-24-3721. PMID: 40540301. Interventional study˰ ˍ